Literature DB >> 31625136

Autoimmune conditions and primary central nervous system lymphoma risk among older adults.

Parag Mahale1, Megan M Herr1,2, Eric A Engels1, Ruth M Pfeiffer1, Meredith S Shiels1.   

Abstract

Primary central nervous system lymphoma (PCNSL) risk is highly increased in immunosuppressed individuals, such as those with human immunodeficiency virus infection and solid organ transplant recipients, but rates are increasing among immunocompetent older adults (age ≥65 years). We utilized data from a large, nationally-representative cohort of older adults in the United States and found that PCNSL is significantly associated with systemic lupus erythematosus, polyarteritis nodusa, autoimmune hepatitis, myasthenia gravis and uveitis. Immunosuppressive drugs given to treat these conditions may increase PCNSL risk, but these associations cannot explain the observed temporal increase in PCNSL rates, given the low prevalence of these conditions.
© 2019 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  SEER-Medicare; autoimmune conditions; myasthenia gravis; primary central nervous system lymphoma; systemic lupus erythematosus

Mesh:

Substances:

Year:  2019        PMID: 31625136      PMCID: PMC7012721          DOI: 10.1111/bjh.16222

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   8.615


  14 in total

Review 1.  Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.

Authors:  Chi-Chao Chan; James L Rubenstein; Sarah E Coupland; Janet L Davis; J William Harbour; Patrick B Johnston; Nathalie Cassoux; Valerie Touitou; Justine R Smith; Tracy T Batchelor; Jose S Pulido
Journal:  Oncologist       Date:  2011-11-01

2.  Primary CNS lymphoma in myasthenic on long-term azathioprine.

Authors:  Pasquale F Finelli
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

3.  Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies.

Authors:  Lesley A Anderson; Shahinaz Gadalla; Lindsay M Morton; Ola Landgren; Ruth Pfeiffer; Joan L Warren; Sonja I Berndt; Winnie Ricker; Ruth Parsons; Eric A Engels
Journal:  Int J Cancer       Date:  2009-07-15       Impact factor: 7.396

Review 4.  Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature.

Authors:  M A Balci; G E Pamuk; E Unlu; U Usta; O N Pamuk
Journal:  Lupus       Date:  2017-02-02       Impact factor: 2.911

5.  Epstein-Barr virus in AIDS-related primary central nervous system lymphoma.

Authors:  E M MacMahon; J D Glass; S D Hayward; R B Mann; P S Becker; P Charache; J C McArthur; R F Ambinder
Journal:  Lancet       Date:  1991-10-19       Impact factor: 79.321

6.  Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study.

Authors:  Todd M Gibson; Lindsay M Morton; Meredith S Shiels; Christina A Clarke; Eric A Engels
Journal:  AIDS       Date:  2014-09-24       Impact factor: 4.177

7.  Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly.

Authors:  Eric A Engels; Ruth M Pfeiffer; Winnie Ricker; William Wheeler; Ruth Parsons; Joan L Warren
Journal:  Am J Epidemiol       Date:  2011-08-04       Impact factor: 4.897

8.  The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009.

Authors:  Meredith S Shiels; Eric A Engels; Martha S Linet; Christina A Clarke; Jianmin Li; H Irene Hall; Patricia Hartge; Lindsay M Morton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-17       Impact factor: 4.254

9.  Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients.

Authors:  Parag Mahale; Meredith S Shiels; Charles F Lynch; Eric A Engels
Journal:  Am J Transplant       Date:  2017-09-02       Impact factor: 9.369

10.  Trends in primary central nervous system lymphoma incidence and survival in the U.S.

Authors:  Meredith S Shiels; Ruth M Pfeiffer; Caroline Besson; Christina A Clarke; Lindsay M Morton; Leticia Nogueira; Karen Pawlish; Elizabeth L Yanik; Gita Suneja; Eric A Engels
Journal:  Br J Haematol       Date:  2016-03-28       Impact factor: 8.615

View more
  2 in total

1.  Primary central nervous system lymphoma in a patient with multiple sclerosis using fingolimod.

Authors:  Matheus Bernardon Morillos; Paulo Henrique Pires de Aguiar; Paulo Roberto Franceschini; Juliana Ávila Duarte; Cristian Daniel Piccini; Alessandro Finkelsztejn
Journal:  Neurol Sci       Date:  2022-08-29       Impact factor: 3.830

2.  Nomograms for predicting cancer-specific survival in patients with primary central nervous system lymphoma: a population-based analysis.

Authors:  Chuanwei Yang; Xiaohui Ren; Yong Cui; Haihui Jiang; Kefu Yu; Mingxiao Li; Xuzhe Zhao; Qinghui Zhu; Song Lin
Journal:  Ann Transl Med       Date:  2021-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.